Effect of Home Testing of International Normalized Ratio on Clinical Events
The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Warfarin anticoagulation reduces thromboembolic complications in patients with atrial fibrillation or mechanical heart valves, but effective management is complex, and the international normalized ratio (INR) is often outside the target range. As compared with venous plasma testing, point-of-care INR measuring devices allow greater testing frequency and patient involvement and may improve clinical outcomes. METHODS: We randomly assigned 2922 patients who were taking warfarin because of mechanical heart valves or atrial fibrillation and who were competent in the use of point-of-care INR devices to either weekly self-testing at home or monthly high-quality testing in a clinic. The primary end point was the time to a first major event (stroke, major bleeding episode, or death). RESULTS: The patients were followed for 2.0 to 4.75 years, for a total of 8730 patient-years of follow-up. The time to the first primary event was not significantly longer in the self-testing group than in the clinic-testing group (hazard ratio, 0.88; 95% confidence interval, 0.75 to 1.04; P=0.14). The two groups had similar rates of clinical outcomes except that the self-testing group reported more minor bleeding episodes. Over the entire follow-up period, the self-testing group had a small but significant improvement in the percentage of time during which the INR was within the target range (absolute difference between groups, 3.8 percentage points; P<0.001). At 2 years of follow-up, the self-testing group also had a small but significant improvement in patient satisfaction with anticoagulation therapy (P=0.002) and quality of life (P<0.001). CONCLUSIONS: As compared with monthly high-quality clinic testing, weekly self-testing did not delay the time to a first stroke, major bleeding episode, or death to the extent suggested by prior studies. These results do not support the superiority of self-testing over clinic testing in reducing the risk of stroke, major bleeding episode, and death among patients taking warfarin therapy. (Funded by the Department of Veterans Affairs Cooperative Studies Program; ClinicalTrials.gov number, NCT00032591.).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although there was no difference in hard endpoints, self-testing gives greater independence and results in a better quality of life.553”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [553]
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 1×
“Minor bleeding, reported 315 (22) 254 (17) <0.”
Harrell, F. E. (2001) · Springer Series in Statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,195
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Pocock, S. J., & Simon, R. (1975) · Biometrics · doi:10.2307/2529712 · Cited by 2,350
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Pharmacology and Management of the Vitamin K Antagonists
Ansell, J., Hirsh, J., Hylek, E., Jacobson, A., Crowther, M., & Palareti, G. (2008) · Chest · doi:10.1378/chest.08-0670 · Cited by 2,118
Self-citationA Method to Determine the Optimal Intensity of Oral Anticoagulant Therapy
Rosendaal, F. R., Cannegieter, S. C., van der Meer, F. J. M., & Briët, E. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1651587 · Cited by 2,065 · cited 1×
“Arrhythmia (other than AF) 158 (11) 160 (11) 0.”
The Health Utilities Index (HUI): concepts, measurement properties and applications.
Horsman, J., Furlong, W. J., Feeny, D. F., & Torrance, G. W. (2003) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-1-54 · Cited by 1,391
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.2307/2670170 · Cited by 1,375
Repeated assessment of results in clinical trials of cancer treatment
Haybittle, J. L. (1971) · The British Journal of Radiology · doi:10.1259/0007-1285-44-526-793 · Cited by 517
Design and Analysis of Quality of Life Studies in Clinical Trials
Fairclough, D. L. (2002) · Chapman & Hall/CRC eBooks · doi:10.1201/9781420035438 · Cited by 461 · cited 1×
“Stroke, major bleeding, or death 271 (19) 285 (20) 0.”
Self-monitoring of oral anticoagulation: a systematic review and meta-analysis
Heneghan, C., Alonso-Coello, P., Garcia-Alamino, J., Perera, R., Meats, E., & Glasziou, P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68139-7 · Cited by 438 · cited 1×
“Nonstroke thrombotic event§§ 34 (2) 41 (3) 0.”
Care of Patients Receiving Long-Term Anticoagulant Therapy
Schulman, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp025373 · Cited by 249
Matchar, D. B., Samsa, G. P., Cohen, S. J., Oddone, E. Z., & Jurgelski, A. E. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01131-2 · Cited by 141 · cited 2×
“Nonstroke thrombotic event§§ 34 (2) 41 (3) 0.”
Self-citationAnsell, J., Jacobson, A. K., Levy, J., Völler, H., & Hasenkam, J. M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2003.11.008 · Cited by 135
Self-citationSamsa, G., Matchar, D. B., Dolor, R. J., Wiklund, I. E., Hedner, E., Wygant, G. D., Hauch, O., Marple, C. B., & Edwards, R. (2004) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-2-22 · Cited by 119
Self-citationMatchar, D. B., Jacobson, A. K., Edson, R., Lavori, P. W., Ansell, J., Ezekowitz, M. D., Rickles, F. R., Fiore, L., Boardman, K., Phibbs, C. S., et al. (2005) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-005-1452-0 · Cited by 33
Self-citationfor the THINRS Site Investigators, Dolor, R. J., Ruybalid, L., Uyeda, L., Edson, R., Phibbs, C. S., Vertrees, J. E., Shih, M., Jacobson, A. K., & Matchar, D. B. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0499-8 · Cited by 21
Self-citationMatchar, D. B., Samsa, G. P., Cohen, S. J., & Oddone, E. Ž. (2000) · Journal of Thrombosis and Thrombolysis · doi:10.1023/a:1018722001817 · Cited by 16
Self-citationAnsell, J., Jaime, J., Salas, M., Dolor, R. J., Corbett, W. E. N., Hudnut, A. G., Seyal, S., Lordan, N. D., Proskorovsky, I., & Wygant, G. D. (2007) · American Journal of Medical Quality · doi:10.1177/1062860607303003 · Cited by 14 · cited 1×
“Stroke, major bleeding, or death 271 (19) 285 (20) 0.”
Self-citation
Cited by
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,115
Authors/Task Force Members, Graham, I., Atar, D., Borch-Johnsen, K., Boysen, G., Burell, G., Cifkova, R., Dallongeville, J., De Backer, G., Ebrahim, S., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,753
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H., Cigarroa, J. E., Cleveland, J. C., Conti, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.022 · Cited by 2,955
January, C. T., Wann, L. S., Calkins, H., Chen, L. Y., Cigarroa, J. E., Cleveland, J. C., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., Furie, K. L., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000665 · Cited by 2,744
Metadata
- Authors
- Matchar, D. B., Jacobson, A., Dolor, R., Edson, R., Uyeda, L., Phibbs, C. S., Vertrees, J. E., Shih, M.-C., Holodniy, M., & Lavori, P.
- Affiliations
- Durham VA Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-10-21
- Volume
- 363
- Issue
- 17
- Pages
- 1608-1620
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2039217072
- Cited by
- 266
- References
- 23
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 4 · 2023: 8 · 2022: 4 · 2021: 14 · 2020: 11 · 2019: 17 · 2018: 11 · 2017: 11 · 2016: 28 · 2015: 10 · 2014: 16 · 2013: 38 · 2012: 39
- FWCI
- 26.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Keywords
- warfarin, international normalized ratio, home self-testing, point-of-care testing, anticoagulation management, atrial fibrillation, mechanical heart valves, stroke prevention, major bleeding, patient satisfaction, quality of life, INR control
- MeSH terms
- Aged, Anticoagulants, Atrial Fibrillation, Female, Follow-Up Studies, Heart Valve Prosthesis, Hemorrhage, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Prospective Studies, Self Care, Thrombosis, Warfarin, Drug Monitoring, International Normalized Ratio, Stroke, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.